Netflix stock: Paramount’s new antitrust hire keeps Warner deal risk in focus

Netflix stock: Paramount’s new antitrust hire keeps Warner deal risk in focus

February 14, 2026

New York, Feb 14, 2026, 10:39 EST — The market has closed.

  • Netflix shares climbed on Friday. Traders, meanwhile, remained focused on the disputed Warner Bros transaction.
  • Paramount has brought in a former U.S. antitrust official to take on a top public policy position, as the bidding war grinds forward.
  • With markets shut for Monday’s holiday, traders will look to Tuesday’s reopening for the next stock action.

Netflix stock finished higher Friday, but as the holiday weekend looms, deal chatter is heating up again. Paramount Skydance tapped Rene Augustine, who served as a Trump administration lawyer, to take over as senior vice president of global public policy. According to a memo from Chief Legal Officer Makan Delrahim, Augustine will focus on “develop[ing] strategic policies” and forging ties aligned with Paramount’s interests. She starts Feb. 17. The addition comes just as Paramount and Netflix are locking horns over Warner Bros Discovery. Paramount is now offering a “ticking fee”—paying extra per quarter for any delay—and says it will pick up a $2.8 billion breakup fee if Warner ditches Netflix. Netflix, for its part, has put forward a $27.75 per share all-cash bid for Warner assets. Reuters

That’s relevant as U.S. markets stay closed Monday for Presidents’ Day, giving deal headlines — plus any regulatory chatter — extra room to ripple before trading picks up again Tuesday.

Netflix stock closed out Friday at $76.87, gaining roughly 1.3% for the session.

Deal chatter around Warner is attracting event-driven funds. Sachem Head, the activist, ramped up its Warner stake to almost 8 million shares by late fourth quarter, a filing revealed. That’s more pressure for management, with Paramount still pressing its rival offer.

Macro drivers are back in view. January’s U.S. consumer price report landed Friday with a softer-than-forecast rise, though services inflation is still sticky — leaving traders to hash out how soon the Fed might move on rates, and what that spells for growth stocks or the cost of capital.

Lower yields might give Netflix a slight lift, though lately the stock’s been behaving more like a merger proxy. The questions haven’t changed—just gotten more pressing: Will regulators sign off on the Warner deal, and how big will the price tag be?

Paramount’s move to bring on a policy expert signals it’s bracing for a tough, drawn-out review. Netflix investors, on the other hand, are left weighing if the all-cash setup marks an advantage—or simply ups the risk.

Plenty could derail things. A lengthy antitrust review might halt progress, inflate expenses, or demand changes that alter the deal’s economics. If bidding heats up, prices could jump, margins could shrink — and if markets suddenly sour, the risks only grow.

Trading resumes Tuesday, Feb. 17. Investors are on alert for new filings or public moves that might raise the temperature — particularly signs of a looming boardroom clash at Warner, or developments that could tilt the odds for which bidder, if any, has a real shot at sealing a deal.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Imugene Seeks ASX Nod to Quote More Ordinary Shares
    July 9, 2026, 3:14 AM EDT. Imugene Limited has filed an Appendix 2A with the Australian Securities Exchange (ASX) requesting approval for the quotation of additional ordinary fully paid shares. The company wants to boost its share capital with this move. Imugene is looking to shore up its equity base, which could affect market cap and share liquidity. Investors may want to watch for updates on approval.